Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Open in API
Filings indexed 309 across all filing types
Latest filing 2024-05-27 Investor Presentation
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation for the quarter & year ended March 31, 2024' and is addressed to stock exchanges as per SEBI regulations. It contains detailed financial data including quarterly and full-year operational metrics, profit and loss summary, balance sheet, cash flow statement, and management commentary. The content is typical of an investor presentation focusing on financial performance, strategy, and market position. The document length is substantial (15,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, it fits the category of an Investor Presentation (IP).
2024-05-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the issuance of a 'Letter of Confirmation' to a shareholder in lieu of a lost share certificate. The content is a regulatory compliance announcement related to share certificate replacement, not a financial report, management change, or voting result. The document length is short (1593 characters) and it serves as a formal notification to the exchanges. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-27 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of newspaper publications of financial results for the period ending March 31, 2024. It references compliance with SEBI regulations and encloses copies of the newspaper publication of financial results. The document itself does not contain the financial results or detailed financial statements but is an announcement of the publication of such results. The document length is short (1560 characters), and it states that the financial results are published in newspapers and enclosed. Therefore, this is an announcement related to the publication of financial results rather than the financial report itself. According to the rules, such documents are classified as Report Publication Announcements (RPA).
2024-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a notice from NGL Fine-Chem Limited to stock exchanges about a scheduled conference call with investors and analysts to discuss the audited financial results for the quarter and year ended March 31, 2024. It includes details about the date, time, participants, and registration information for the call. The document does not contain actual financial data or detailed financial analysis but is an announcement of an upcoming event where such information will be discussed. Therefore, it is not an earnings release or a full report but a conference call invitation/announcement. According to the filing definitions, this fits the category of a Call Transcript (CT) document type, as it relates to a conference call with investors. However, since this is only an invitation and not the transcript itself, the closest appropriate category is Call Transcript (CT) because no other category fits better and it is related to a conference call event.
2024-05-23 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of NGL Fine-Chem Limited dated May 21, 2024. It includes the outcome of the Board Meeting where the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2024, were approved along with the statutory auditor's report. It also mentions the statement of assets and liabilities, recommendation of final dividend, notice of the ensuing Annual General Meeting, and appointments of auditors and scrutinizer. The document contains actual financial data including revenue, expenses, profit/loss figures, and tax expenses for the relevant fiscal periods. This comprehensive financial data and the approval of audited results indicate that this is the official Annual Report or Annual Financial Results filing rather than a mere announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K) type filing.
2024-05-22 English
Book Closure
Board/Management Information Classification · 95% confidence The document is a formal letter dated May 21, 2024, from the company NGL Fine-Chem Limited addressed to stock exchanges (BSE and NSE). It announces the outcome of a Board Meeting held on the same date. The content includes approval of audited financial results for the quarter and year ended March 31, 2024, recommendation of a final dividend, notice of the upcoming Annual General Meeting (AGM), appointment of auditors and scrutinizer, and other administrative decisions. The document does not contain the full audited financial results or detailed financial statements but rather summarizes decisions made by the Board. It is an announcement of the Board Meeting outcomes rather than the full Annual Report or financial statements. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management changes or approvals. The document length is 3108 characters, which is relatively short and consistent with a meeting outcome announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2024-05-21 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.